Subscribe to Drug Discovery & Development Articles

The Lead

Promising Malaria and Dengue Vaccines Will Not Defeat Diseases

May 20, 2015 | by Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases | Comments

Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...


Diagnostic Screening for Alzheimer’s Disease: Economics, Policy, and Unanswered Questions

April 28, 2016 10:01 am | by Jillian Godfrey Scaife, Principal, and Nick Simmons-Stern, Consultant, Trinity Partners | Comments

In recent years, there has been a resurgence in the number of Alzheimer’s disease (AD) clinical trials, led by major efforts from Biogen, Lilly, Genentech/Roche, and others. With the first of these novel AD therapies potentially coming to market as early as 2017/2018, there are a number of critical and as yet unanswered questions surrounding the economics and policy of AD diagnostic screening. 


The New Focus on IL-12 in Oncology Research

April 26, 2016 3:23 pm | by Dr. Premal Thaker M.D., Washington University School of Medicine; Dr. Charles Leath III, M.D., University of Alabama School of Medicine | Comments

In recent years, researchers have made considerable headway in efforts to improve both the pharmacokinetics and safety of therapies based on rIL-12 based on the use of more advanced delivery mechanisms.


South Korean Pharmaceutical Market to Experience Slow Four-Year Growth

April 26, 2016 2:00 pm | by Adam Dion, MSc, Senior Industry Analyst, GlobalData | Comments

Many novel drugs are set to lose their patents by 2020, meaning South Korea’s generics market is expected to increase significantly.


Early-Morning Flu Shots are More Potent, Suggests Study

April 26, 2016 12:28 pm | by Ryan Bushey, Digital Editor | Comments

Vaccinations for three different influenza strains were given to an approximate 276 adults, over the age of 65.


New R&D Pact Seeks Cure for Aging-Related Diseases

April 26, 2016 10:06 am | by Ryan Bushey, Digital Editor | Comments

Google’s Calico, an institution with a mysterious mission to “cure death” could have competition from a new collaboration between Ascentage Pharma and Unity Biotechnology.


Study Proves Anti-Smoking Pills Don't Raise Suicide Risk

April 26, 2016 10:06 am | by Ryan Bushey, Digital Editor | Comments

Over the course of 12 weeks, patients were administered either Chantix or Zyban, a nicotine patch, or a placebo followed by an additional 12 weeks of follow-up.


University Develops First Diagnostic Blood Test for Parkinson's

April 22, 2016 11:04 am | by Greg Watry, Digital Reporter | Comments

The university reported the test has undergone trials with 38 people, 29 with Parkinson’s and nine without.


Global Viral Infections Market to Reach $117.6B by 2021

April 22, 2016 10:58 am | by Fiona Chisholm, Analyst, GBI Research | Comments

The availability of generic drugs is expected to increase due to a series of recent and upcoming patent expirations for key marketed products, particularly within HIV.


Orphan Status Granted to GW's Cannabis Drug

April 21, 2016 10:23 am | by Ryan Bushey, Digital Editor | Comments

This disease marks the third treatment indication GW is pursuing.


Biden Urges Cancer Researchers to Collaborate, Calls for Guidance

April 20, 2016 4:39 pm | by Stephanie Guzowski, Editor | Comments

Vice President Joe Biden encouraged the nation’s leading cancer researchers to collaborate more effectively and to share data in an effort to accelerate ambitious cancer research goals, at the American Association for Cancer Research annual meeting.


Multi-Blockbuster Drugs Will Drive Immuno-Oncology Market to $34B

April 19, 2016 8:40 am | by Dan Roberts, Ph.D., Senior Oncology & Hematology Analyst, GlobalData | Comments

Immuno-oncology products have demonstrated comparable respective efficacy and safety profiles.


Gilead, AbbVie Tout Impressive Data for Hepatitis C Drugs

April 18, 2016 9:27 am | by Ryan Bushey, Digital Editor | Comments

These results bode well for individuals suffering from this disease. 


Generic Allergy Drug May Fix Eye Nerve Damage in MS Patients

April 14, 2016 10:39 am | by Ryan Bushey, Digital Editor | Comments

Scientists discovered this over-the-counter drug could have special properties. 


Napster Co-Founder Funds Immunotherapy Research Project

April 14, 2016 8:45 am | by Ryan Bushey, Digital Editor | Comments

Stanford, Memorial Sloan Kettering Cancer Center, and the University of Pennsylvania are some of the institutions taking part in this endeavor.


Precision Medicine: An Internal Crusade Within Our Own Biology

April 13, 2016 9:50 am | by Dr. Michael Kiebish, Chief Precision Medicine Officer, BERG Health | Comments

In the new frontier of precision medicine, today’s explorers do not emulate Ferdinand Magellan, Vasco da Gama, John Smith, or Neil Armstrong, wielding armor and protective gear to combat attackers or the elements. 



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.